Evaluation of CTFFR for Identifying Non-Significant Coronary Lesions and Predicting Major Cardiovascular Events Over One Year
Led by Shiraz University of Medical Sciences · Updated on 2025-05-21
250
Participants Needed
1
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
This research investigates the use of a diagnostic test called fractional flow reserve derived from CT angiography NIFFR in patients with known or suspected chronic coronary syndrome CAD. It focuses on patients who have at least one coronary artery lesion with 50-70% narrowing. The study aims to see if NIFFR can identify lesions that are not significant and predict major heart-related events over a one-year period.
Participants had coronary computed tomography angiography CCTA and invasive coronary angiography ICA with FFR measurements. The study included 250 patients with intermediate coronary lesions and NIFFR values above 0.80. Their coronary artery lesions were carefully measured and classified using advanced imaging software. The study groups compared patients with nonsignificant NIFFR and those with significant NIFFR values.
Over one year, patients were followed closely, with visits every three months and phone calls to monitor for major adverse cardiovascular events MACE, including heart-related death, acute coronary syndrome, unexpected procedures to restore blood flow, and hospitalizations due to heart problems. Researchers collected detailed patient information including heart function, lesion characteristics, and cardiovascular risk factors. Outcomes such as MACE, bleeding, and shortness of breath were tracked to evaluate the diagnostic value of NIFFR in predicting heart health risks.
CONDITIONS
Brief Title
CTFFR and Prediction of Non-Significant CAD Lesions
Research Team
J
javad UOM kojuri
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patients with at least one intermediate coronary lesion (50-70% diameter narrowing) seen on coronary computed tomography angiography (CCTA)
Patients who underwent fractional flow reserve (FFR) testing
Adults aged between 20 and 80 years
You will not qualify if you...
History of coronary artery bypass graft surgery (CABG)
Previous percutaneous coronary intervention (PCI) in the target vessel
Significant kidney impairment with estimated glomerular filtration rate (eGFR) less than 30 mL/min/1.73 m²
Allergy to contrast agents used in imaging
Poor image quality preventing proper CCTA or CT-FFR analysis
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Diagnostic Evaluation
Duration - Up to 1 week
Participants undergo coronary computed tomography angiography (CCTA) and fractional flow reserve (FFR) testing to evaluate coronary artery lesions.
1 to 2 visits (in-person)
Long-term Monitoring
Duration - 1 year
Participants are clinically monitored for one year to assess major cardiovascular events and other health outcomes.
Quarterly visits and phone follow-ups every 3 months
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Similar Trials
Comparing Intravascular Ultrasound-Guided and Experienced Angiography-Guided Stenting
for Left Main Coronary Artery Bifurcation Lesions
A Prospective Randomized Clinical Trial
Study of Blood Factors and Disease Links in Adults With Acute and Chronic Coronary Syndrome Compared to Healthy Controls
Investigating Advanced Invasive Diagnosis to Identify Causes of Angina After PCI in Stable Coronary Syndrome Patients
Study of Angiography-Based Vessel Fractional Flow Reserve After PCI
Assessing Impact on Clinical Outcomes and Angina in Coronary Syndrome Patients
AI-Driven Angiography-Based Fractional Flow Reserve Compared to Invasive FFR to Guide PCI in Coronary Artery Disease
Comparing Low-Dose and Standard-Dose Aspirin Combined With a P2Y12 Inhibitor After PCI to Prevent Cardiac Events
Study on Plasma NT-proBNP Levels and Coronary Artery Disease Severity
in Patients Undergoing Elective Coronary Angiography
Study on Adherence to 2019 European Society of Cardiology Guidelines for Chronic Coronary Syndrome in Adults
Evaluating Common Femoral Vein-to-Artery Diameter Ratio to Detect Elevated Left Ventricular Pressure in Adults Undergoing Heart Catheterization
Comparing Prasugrel Plus Low-Dose Aspirin to High- and Low-Dose Aspirin Alone
for Three Months Following Coronary Artery Bypass Grafting in Chronic Coronary Disease
OPTIMUS-CABG Trial
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Evaluation of the ability of CTFFR to determine non-significant lesions of coronary disease based on MACE in one-year follow-up of patients (seeing beyond the stenosis: CTFFR and MACE in a one-year follow-up).